7/19/2021 | BK | S&P shifts Curia Global view to negative
|
7/16/2021 | BK | Moody's cuts Curia, gives B2 to add-on
|
4/19/2021 | BK | S&P ups Albany Molecular
|
10/27/2020 | BK | Albany Molecular allocates first-lien term loan at Libor plus 350 bps
|
10/22/2020 | BK | Market Commentary: Hyperion, Help at Home, Adevinta, Sovos break; Barracuda, Albany Molecular update deals
|
10/22/2020 | BK | Albany Molecular flexes $210 million term loan to Libor plus 350 bps
|
10/21/2020 | BK | Market Commentary: Rough Country breaks; Adevinta, Sovos updated; PAI, Barracuda, Albany Molecular accelerated
|
10/19/2020 | BK | Market Commentary: Quirch, Mega Broadband break; Chobani tweaks deal; MultiPlan, Les Schwab and more set talk
|
10/19/2020 | BK | Moody’s ups Albany Molecular rates facility B2
|
10/19/2020 | BK | S&P gives Albany Molecular loan B-
|
10/19/2020 | BK | Albany Molecular talks $210 million term loan at Libor plus 375 bps
|
10/16/2020 | BK | Market Commentary: 1-800 Contacts frees up; Filtration Group, Mega Broadband, Ascend Learning changes emerge
|
10/16/2020 | BK | Albany Molecular to launch $210 million term loan on Monday
|
8/31/2020 | BK | S&P shifts Albany Molecular view to stable
|
6/26/2019 | BK | S&P downgrades Albany Research
|
6/20/2018 | BKCV | S&P changes Albany Molecular view
|
7/28/2017 | BK | Market Commentary: Heartland, Avast, EnergySolutions, Albany Molecular, Culligan, Victory, FleetCor break
|
7/27/2017 | BK | Market Commentary: CareerBuilder, Flying Fortress, J.D. Power break; GNC term loan rises on quarterly numbers
|
7/27/2017 | BKCV | S&P lowers Albany Molecular’s first-lien loans
|
7/27/2017 | BK | Albany Molecular upsizes first-lien term loan, tightens pricing
|
7/24/2017 | BK | Market Commentary: Zebra, Peak 10, YRC break; Diversey, Duravant, CPI, U.S. Security, Sky Betting set changes
|
7/19/2017 | BK | Market Commentary: Cypress, Arterra, Midcontinent break; HD Supply Waterworks, CPM, Interface tweak deals
|
7/19/2017 | BKCV | Moody’s: UIC Merger/Albany Molecular facilities B2, Caa2
|
7/19/2017 | BK | Albany Molecular discloses first- and second-lien term loan price talk
|
7/19/2017 | BKCV | S&P: Albany Molecular loans B+, B-
|
7/17/2017 | BK | Market Commentary: Zebra trades slightly lower with repricing; near-term new issue calendar continues to build
|
7/17/2017 | BK | Albany Molecular to launch $925 million credit facilities on Wednesday
|
7/5/2017 | BK | Albany Molecular plans $960 million credit facilities for buyout
|
6/7/2017 | BKCV | S&P might lower Albany Molecular
|
6/6/2017 | BK | Albany Molecular plans new debt for buyout by Carlyle and GTCR
|
12/20/2016 | BKDDHY | S&P acts on U.S. pharmaceuticals
|
6/6/2016 | BK | Market Commentary: Generation Brands, Albany Molecular update deals; primary activity continues to blossom
|
6/6/2016 | BK | Albany Molecular firms discount on $230 million add-on term loan at 99
|
5/24/2016 | BK | Market Commentary: Verisk Health breaks; TransDigm dips with acquisition news; BMC Software trades higher
|
5/24/2016 | BK | Albany Molecular launches $230 million add-on term loan to investors
|
5/11/2016 | BKCVDD | S&P lowers Albany Molecular loans to B
|
5/6/2016 | BK | Albany Molecular gets commitment for planned Euticals acquisition
|
8/19/2015 | BK | Market Commentary: US LBM frees to trade; KIK Custom Products modifies loan; Townsquare moves up deadline
|
8/14/2015 | BK | Market Commentary: CPI Card, Duff & Phelps, Hudson’s Bay, Patterson, Albany Molecular break; Avago tweaks deal
|
8/14/2015 | BK | Market Commentary: CPI Card, Duff & Phelps, Patterson Medical, Albany Molecular break; Avago tweaks deals
|
8/13/2015 | BK | Market Commentary: Owens-Brockway Glass, Knowledge Universe, AMAG Pharmaceuticals, Vistage, USI free to trade
|
7/29/2015 | BK | Market Commentary: Hostess, Jarden, Peacock Engineering, Precyse, Ascena Retail, EagleView Technology break
|
7/29/2015 | BK | Albany Molecular launches $200 million term B at Libor plus 475 bps
|
7/27/2015 | BK | Market Commentary: Alliant Insurance, Universal Services, Numericable break; Hostess, Jarden changes revealed
|
7/27/2015 | BKCV | Moody’s rates Albany Molecular CFR B3, loans B1
|
7/27/2015 | BK | Albany Molecular to launch $230 million credit facility on Wednesday
|
7/24/2015 | BKCVDD | S&P rates Albany Molecular loans B+, convertibles CCC+
|
7/16/2015 | BK | Albany Molecular obtains $200 million term loan, $30 million revolver
|
12/30/2014 | BK | Albany Molecular lifts three-year revolver commitments to $75 million
|